Elevance Health, Inc. (ELV)
(Delayed Data from NYSE)
$505.16 USD
-6.10 (-1.19%)
Updated Oct 2, 2024 04:00 PM ET
After-Market: $505.17 +0.01 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth B Momentum C VGM
Income Statements
Fiscal Year end for Elevance Health, Inc falls in the month of December .
All items in Millions except EPS data.
12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | |
---|---|---|---|---|---|
Sales | 171,340 | 156,595 | 138,639 | 121,867 | 104,213 |
Cost Of Goods | 141,623 | 129,522 | 113,540 | 96,998 | 83,778 |
Gross Profit | 29,717 | 27,073 | 25,099 | 24,869 | 20,435 |
Selling & Adminstrative & Depr. & Amort Expenses | 20,972 | 18,453 | 16,355 | 17,811 | 13,702 |
Income After Depreciation & Amortization | 8,745 | 8,620 | 8,744 | 7,058 | 6,733 |
Non-Operating Income | 0 | 0 | -21 | -36 | -2 |
Interest Expense | 1,030 | 851 | 798 | 784 | 746 |
Pretax Income | 7,715 | 7,769 | 7,925 | 6,238 | 5,985 |
Income Taxes | 1,724 | 1,750 | 1,830 | 1,666 | 1,178 |
Minority Interest | 4 | -6 | -9 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 5,991 | 6,019 | 6,095 | 4,572 | 4,807 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 5,987 | 6,025 | 6,104 | 4,572 | 4,807 |
Depreciation Footnote | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 10,490 | 10,295 | 10,046 | 8,212 | 7,866 |
Depreciation & Amortization (Cash Flow) | 1,745 | 1,675 | 1,302 | 1,154 | 1,133 |
Income After Depreciation & Amortization | 8,745 | 8,620 | 8,744 | 7,058 | 6,733 |
Earnings Per Share Data | 12/31/23 | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 |
---|---|---|---|---|---|
Average Shares | 237.40 | 242.80 | 246.80 | 254.30 | 260.30 |
Diluted EPS Before Non-Recurring Items | 33.14 | 29.07 | 25.98 | 22.48 | 19.44 |
Diluted Net EPS (GAAP) | 25.22 | 24.81 | 24.73 | 17.98 | 18.47 |
Fiscal Year end for Elevance Health, Inc falls in the month of December .
All items in Millions except EPS data.
9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 | |
---|---|---|---|---|---|
Sales | 43,886.00 | 42,577.00 | 42,647.00 | 42,849.00 | 43,672.00 |
Cost Of Goods | 35,392.00 | 34,371.00 | 36,171.00 | 35,254.00 | 35,931.00 |
Gross Profit | 8,494.00 | 8,206.00 | 6,476.00 | 7,595.00 | 7,741.00 |
SG&A, R&D, and Dept/Amort Expenses | 5,228.00 | 5,002.00 | 5,216.00 | 5,682.00 | 5,039.00 |
Income After SG&A, R&D, and Dept/Amort Expenses | 3,266.00 | 3,204.00 | 1,260.00 | 1,913.00 | 2,702.00 |
Non-Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 280.00 | 265.00 | 259.00 | 259.00 | 261.00 |
Pretax Income | 2,986.00 | 2,939.00 | 1,001.00 | 1,654.00 | 2,441.00 |
Income Taxes | 685.00 | 690.00 | 170.00 | 354.00 | 585.00 |
Minority Interest | 1.00 | 3.00 | -25.00 | 11.00 | 3.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | 2,301.00 | 2,249.00 | 831.00 | 1,300.00 | 1,856.00 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | 2,300.00 | 2,246.00 | 856.00 | 1,289.00 | 1,853.00 |
Earnings Per Share Data | 9/30/24 | 6/30/24 | 3/31/24 | 12/31/23 | 9/30/23 |
---|---|---|---|---|---|
Average Shares | 233.40 | 234.20 | 235.80 | 236.50 | 237.80 |
Diluted EPS Before Non-Recurring Items | 10.12 | 10.64 | 5.62 | 8.99 | 9.04 |
Diluted Net EPS (GAAP) | 9.85 | 9.59 | 3.68 | 5.45 | 7.79 |